Feedback / Questions
taladegib (ENV 101) - Endeavor BioMed
...Phase 2b WHISTLE-PF trial, which is on track and expected to be completed in 2026
(Businesswire)
Sep 30, 2025
Trial completion date
•
Idiopathic Pulmonary Fibrosis
https://www.businesswire.com/news/home/20250929248127/en/Endeavor-BioMedicines-Announces-Publication-of-Positive-Data-from-Phase-2a-Trial-in-The-Lancet-Respiratory-Medicine-Evaluating-taladegib-ENV-101-in-Individuals-with-Idiopathic-Pulmonary-Fibrosis
Sep 30, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next